Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer - Monk, Bradley J.; Herzog, Thomas J.; Kaye, Stanley B.; Krasner, Carolyn N.; Vermorken, Jan B.; Muggia, Franco M.; Pujade-Lauraine, Eric; Lisyanskaya, Alla S.; Makhson, Anatoly N.; Rolski, Janusz; Gorbounova, Vera A.; Ghatage, Prafull; et al. (Journal of clinical oncology, 2010)
Keywords: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols - adverse effects; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Dioxoles - administration & dosage; Dioxoles - adverse effects; Doxorubicin - administration & dosage; Doxorubicin - adverse effects; Doxorubicin - analogs & derivatives; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Leukopenia - chemically induced; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neutropenia - chemically induced; Ovarian Neoplasms - drug therapy; Ovarian Neoplasms - pathology; Polyethylene Glycols - administration & dosage; Polyethylene Glycols - adverse effects; Stomatitis - chemically induced; Tetrahydroisoquinolines - administration & dosage; Tetrahydroisoquinolines - adverse effects; Treatment Outcome